Sol-Gel Technologies (SLGL) News
NASDAQ: SLGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
55.17+1.09 (+2.02%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SLGL news summary
We found 4 recent headlines mentioning Sol-Gel Technologies (SLGL): 1 in the past week and 3 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, SLGL is up 2.02% at $55.17. The most recent story, "Sol-Gel Technologies Ltd. Shareholders Approve CEO Appointment and Potential Name Change", was published by Nasdaq on Nov 17, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Sol-Gel Technologies headlines
- Sol-Gel Technologies Ltd. Shareholders Approve CEO Appointment and Potential Name ChangeSol-Gel Technologies Ltd. announced that several resolutions were approved at its Annual Meeting of Shareholders. Shareholders approved the appointment of Mr. Moshe Arkin, the current interim Chief…Nasdaq
- Sol-Gel Technologies Ltd. Reports Third Quarter 2026 Financial Results and SGT-610 Clinical ProgressSol-Gel Technologies Ltd. announced its financial results for the third quarter ended September 30, 2026, and provided corporate updates. The company reported that its pivotal Phase 3 clinical trial…Nasdaq
- Sol-Gel Reports Third Quarter 2026 Financial Results and Provides Corporate UpdatesSol-Gel Reports Third Quarter 2026 Financial Results and Provides Corporate UpdatesGlobeNewswire
- Cantor Fitzgerald Initiates Coverage of Sol-Gel Technologies at OverweightCantor Fitzgerald initiated coverage of Sol-Gel Technologies (NASDAQCM:SLGL) (DB:4SG) with a Overweight recommendation on October 14, 2026. Sol-Gel Technologies Ltd. is a pharmaceutical company based…Nasdaq